A detailed history of Silvercrest Asset Management Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 64,200 shares of BSX stock, worth $5.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
64,200
Previous 56,941 12.75%
Holding current value
$5.78 Million
Previous $4.39 Million 22.67%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $529,616 - $609,756
7,259 Added 12.75%
64,200 $5.38 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $3.83 Million - $4.42 Million
-56,941 Reduced 50.0%
56,941 $4.39 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $4.25 Million - $4.9 Million
63,074 Added 124.14%
113,882 $8.77 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $641,548 - $764,289
11,138 Added 28.08%
50,808 $3.48 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $1.59 Million - $1.89 Million
32,733 Added 471.86%
39,670 $2.29 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $646 - $710
-13 Reduced 0.19%
6,937 $375,000
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $435 - $519
-11 Reduced 0.16%
6,950 $321,000
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $73,420 - $219,320
-2,000 Reduced 22.32%
6,961 $270,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $14,413 - $19,263
-409 Reduced 4.36%
8,961 $334,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $449 - $496
11 Added 0.12%
9,370 $415,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $125,174 - $147,532
-3,288 Reduced 26.0%
9,359 $398,000
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $23,624 - $26,289
-573 Reduced 4.33%
12,647 $549,000
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $12,345 - $14,156
320 Added 2.48%
13,220 $565,000
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $304,203 - $342,153
-8,625 Reduced 40.07%
12,900 $499,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $33,647 - $42,599
-1,015 Reduced 4.5%
21,525 $774,000
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $120,760 - $156,440
4,000 Added 21.57%
22,540 $791,000
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $214,389 - $379,393
8,300 Added 81.05%
18,540 $605,000
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $31,844 - $34,325
790 Added 8.36%
10,240 $417,000
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $5,934 - $7,306
-170 Reduced 1.77%
9,450 $406,000
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $6,500 - $7,648
-198 Reduced 2.02%
9,620 $370,000
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $671 - $858
-25 Reduced 0.25%
9,818 $321,000
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $61,082 - $73,427
-2,464 Reduced 20.02%
9,843 $244,000
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $323,181 - $358,995
12,307
12,307 $359,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.